Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

402
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
402

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How to frustrate a plant pathogen.

The Plant journal : for cell and molecular biology·2026
Same author

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

Blood advances·2026
Same author

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

Research square·2025
Same author

A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

bioRxiv : the preprint server for biology·2025
Same author

C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>.

Haematologica·2025
Same author

Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jan 14, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

Preoperative Radiotherapy in Elderly Patients With Locally Advanced Rectal Cancer: A Retrospective Cohort Study.

Jacob F Wahba1, Mohab Husien2, Bogdan Paun3

  • 1Faculty of Health Sciences, Wilfrid Laurier University, Waterloo, CAN.

Cureus
|October 24, 2025
PubMed
Summary

Short-course radiotherapy (SCRT) and chemoradiotherapy (CRT) are effective treatments for elderly patients with locally advanced rectal cancer (LARC), offering comparable survival outcomes and low recurrence rates. Both modalities were well-tolerated, with SCRT providing greater flexibility and fewer complications.

Keywords:
geriatric oncologylocally advanced rectal cancerneoadjuvant chemoradiotherapyneoadjuvant radiation treatmentoncological outcomesrectal cancershort-course radiotherapysurvival analysis

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

640

Related Experiment Videos

Last Updated: Jan 14, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

640

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Locally advanced rectal cancer (LARC) poses treatment challenges in elderly patients (≥75 years).
  • Optimizing treatment strategies for this demographic is crucial for improving outcomes while minimizing toxicity.

Purpose of the Study:

  • To compare the outcomes of elderly patients with LARC treated with either short-course radiotherapy (SCRT) or chemoradiotherapy (CRT).
  • To evaluate the safety and efficacy of SCRT versus CRT in this specific patient population.

Main Methods:

  • Retrospective chart review of 46 patients (≥75 years) with LARC treated between 2017-2020.
  • Comparison of outcomes between SCRT (25 Gy/5 fractions) and CRT (50.4 Gy/28 fractions with capecitabine), followed by surgery.
  • Assessment of surgical margins, pathological complete response (pCR), local recurrence, distant metastasis (DM), overall survival (OS), and cancer-specific survival (CSS).

Main Results:

  • R0 resection rates were high in both groups (86% SCRT, 100% CRT).
  • No pCR observed; local recurrence was low (5.9% SCRT, 0% CRT).
  • No statistically significant differences in OS (73.5% SCRT vs. 75% CRT) or CSS (73.5% SCRT vs. 91.7% CRT) at 24 months median follow-up.

Conclusions:

  • Both SCRT and CRT are well-tolerated and effective for elderly LARC patients, achieving high R0 resection rates and low recurrence.
  • CRT demonstrated a trend towards better nodal downstaging, while SCRT offered comparable survival with improved treatment flexibility and fewer complications.